Benoît Guery

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


271 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ...
In press
 
Association of persistent positive blood cultures and infective endocarditis: a cohort study among patients with suspected infective endocarditis.
Antunes A.T., Monney P., Tzimas G., Tozzi P., Kirsch M., Guery B., Papadimitriou-Olivgeris M. International journal of infectious diseases. Peer-reviewed.
[DOI][Pmid][serval:BIB_E1FB82714E70]
 
Predictors of mortality of streptococcal bacteremia and the role of infectious diseases consultation; a retrospective cohort study.
Fourre N., Zimmermann V., Senn L., Aruanno M., Guery B., Papadimitriou-Olivgeris M. Clinical infectious diseases. Peer-reviewed.
[DOI][Pmid][serval:BIB_FBE241ACE9B2]
 
Evaluation of the 2023 Duke-ISCVID criteria in a multicenter cohort of patients with suspected infective endocarditis.
Papadimitriou-Olivgeris M., Monney P., Frank M., Tzimas G., Tozzi P., Kirsch M., Van Hemelrijck M., Bauernschmitt R., Epprecht J., Guery B. et al. Clinical infectious diseases. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_12B06D51FBFF]
2024
 
Heterogeneity in practices to reduce the risk of transmission of Clostridioides difficile in healthcare settings: a survey of ESCMID Study Group for Clostridioides difficile (ESGCD) members.
Khanafer N.L., Fitzpatrick F., Barbut F., Krutova M., Davies K., Guery B., Vanhems P., 2024/04. European journal of clinical microbiology & infectious diseases, 43 (4) pp. 785-789. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3C410AF6ADD0]
 
Update on microbiota-derived therapies for recurrent Clostridioides difficile infections.
Benech N., Barbut F., Fitzpatrick F., Krutova M., Davies K., Druart C., Cordaillat-Simmons M., Heritage J., Guery B., Kuijper E. et al., 2024/04. Clinical microbiology and infection, 30 (4) pp. 462-468. Peer-reviewed.
[DOI][Pmid][serval:BIB_BDCA9D3574BD]
 
Evaluation of the 2023 Duke-ISCVID and 2023 Duke-ESC Clinical Criteria for the Diagnosis of Infective Endocarditis in a Multicenter Cohort of Patients With Staphylococcus aureus Bacteremia.
Papadimitriou-Olivgeris M., Monney P., Frank M., Tzimas G., Tozzi P., Kirsch M., Van Hemelrijck M., Bauernschmitt R., Epprecht J., Guery B. et al., 2024/03/20. Clinical infectious diseases, 78 (3) pp. 655-662. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DB75393A32ED]
 
Eyes Wide Shut: A Cohort Study Questioning the Role of Fundoscopy in Infective Endocarditis Diagnosis.
Stavropoulou E., Guery B., Tzimas G., Guex-Crosier Y., Hoogewoud F., Tozzi P., Kirsch M., Monney P., Papadimitriou-Olivgeris M., 2024/03/20. Clinical infectious diseases, 78 (3) pp. 663-666. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7A196BAF31FB]
Evaluation of the Clinical Rule for Endocarditis in the Emergency Department Among Patients With Suspected Infective Endocarditis.
Papadimitriou-Olivgeris M., Monney P., Carron P.N., Tzimas G., Beysard N., Tozzi P., Kirsch M., Guery B., 2024/02/20. Journal of the American Heart Association, 13 (4) pp. e032745. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C60BEFF89C38]
Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care Patients.
Schrijver I.T., Herderschee J., Théroude C., Kritikos A., Leijte G., Le Roy D., Brochut M., Chiche J.D., Perreau M., Pantaleo G. et al., 2024/02/08. Cells, 13 (4). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AAE7B79746C8]
 
Prevalence of Infective Endocarditis among Patients with Staphylococcus aureus Bacteraemia and Bone and Joint Infections.
Papadimitriou-Olivgeris M., Guery B., Monney P., Senn L., Steinmetz S., Boillat-Blanco N., 2024/02/06. Microorganisms, 12 (2). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7458572CA86C]
 
Re: 'The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes' by Stabholz et al.
van Prehn J., Skinner A.M., Krutova M., Guery B., 2024/02. Clinical microbiology and infection, 30 (2) pp. 261-262. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FC12DB82227A]
Risk of embolic events before and after antibiotic treatment initiation among patients with left-side infective endocarditis.
Papadimitriou-Olivgeris M., Guery B., Ianculescu N., Auberson D., Tozzi P., Kirsch M., Monney P., 2024/02. Infection, 52 (1) pp. 117-128. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A3211E03E289]
 
Which trial do we need? A sequential multiple assignment randomized trial to determine the optimal Clostridioides difficile treatment sequence.
van Prehn J., van Werkhoven C.H., Skinner A.M., Guery B., Dubberke E.R., Kuijper E.J., 2024/02. Clinical microbiology and infection, 30 (2) pp. 165-169. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F505539BEF06]
2023
Core genome multilocus sequence typing of Clostridioides difficile to investigate transmission in the hospital setting.
Filippidis P., Senn L., Poncet F., Grandbastien B., Prod'hom G., Greub G., Guery B., Blanc D.S., 2023/12. European journal of clinical microbiology & infectious diseases, 42 (12) pp. 1469-1476. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DBB82905A18B]
 
Hear my voice: involving patients in Clostridioides difficile infection research.
Strawbridge J., Heritage J., Krůtová M., Guery B., Davies K., Fitzpatrick F., Freeman J., 2023/10. Clinical microbiology and infection, 29 (10) pp. 1222-1224. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A99DE698D533]
Impact of thoracoabdominal imaging on diagnosis and management in patients with suspected infective endocarditis.
Papadimitriou-Olivgeris M., Monney P., Rotzinger D.C., Kamani C.H., Fahrni G., Prior J.O., Ianculescu N., Messaoudi Y., Tozzi P., Kirsch M. et al., 2023/10. European journal of internal medicine, 116 pp. 82-88. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E87D41365F89]
 
Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.
Galperine T., Choi Y., Pagani J.L., Kritikos A., Papadimitriou-Olivgeris M., Méan M., Scherz V., Opota O., Greub G., Guery B. et al., 2023/08/18. BMC infectious diseases, 23 (1) p. 537. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4AC9A4A0DF4]
Role of Cerebral Imaging on Diagnosis and Management in Patients With Suspected Infective Endocarditis.
Papadimitriou-Olivgeris M., Guery B., Ianculescu N., Dunet V., Messaoudi Y., Pistocchi S., Tozzi P., Kirsch M., Monney P., 2023/08/14. Clinical infectious diseases, 77 (3) pp. 371-379. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_00C97D4994EB]
 
The role of early defervescence in ruling out infective endocarditis: a cohort study.
Stavropoulou E., Guery B., Ianculescu N., Tozzi P., Kirsch M., Monney P., Papadimitriou-Olivgeris M., 2023/08. Clinical microbiology and infection, 29 (8) pp. 1087.e5-1087.e8. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D0D08DE9B90E]
 
Highlights of the first edition of the European Conference on Microbiota & Virology: A hybrid event, Paris, 23 March 2023
Psomas Christina K., Serrano-Villar Sergio, Guery Benoit, Halfon Philippe, Marchetti Giulia, 2023/06. Journal of Virus Eradication, 9 (2) p. 100332.
[DOI][WoS][serval:BIB_708AE57BF149]
Dry alginate beads for fecal microbiota transplantation: From model strains to fecal samples.
Rakotonirina A., Galperine T., Audry M., Kroemer M., Baliff A., Carrez L., Sadeghipour F., Schrenzel J., Guery B., Allémann E., 2023/05/25. International journal of pharmaceutics, 639 p. 122961. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1CF66E2BCB5B]
Long-Term Consequences of COVID-19: A 1-Year Analysis.
Bamps L., Armenti J.P., Bojan M., Grandbastien B., von Garnier C., Du Pasquier R., Desgranges F., Papadimitriou-Olivgeris M., Alberio L., Preisig M. et al., 2023/04/03. Journal of clinical medicine, 12 (7) p. 2673. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D74F62B5F2C9]
Clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteraemia.
Papadimitriou-Olivgeris M., Jacot D., Senn L., Guery B., 2023/03. European journal of clinical microbiology & infectious diseases, 42 (3) pp. 379-382. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1DBF56EE5F6D]
Predictors of mortality of Staphylococcus aureus bacteremia among patients hospitalized in a Swiss University Hospital and the role of early source control; a retrospective cohort study.
Papadimitriou-Olivgeris M., Caruana G., Senn L., Guery B., 2023/03. European journal of clinical microbiology & infectious diseases, 42 (3) pp. 347-357. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E5AECF64F721]
 
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection.
Krutova M., Davis K., Guery B., Barbut F., 2023/02. The lancet. Gastroenterology & hepatology, 8 (2) pp. 111-112. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_07C409C697E0]
2022
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations.
Mitropoulou G., Koutsokera A., Csajka C., Blanchon S., Sauty A., Brunet J.F., von Garnier C., Resch G., Guery B., 2022/12/31. European respiratory review, 31 (166) p. 220121. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E890AE6D6C1D]
Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections after 2020 EUCAST criteria update: an observational study in a university hospital.
Munting A., Damas J., Viala B., Prod'hom G., Guery B., Senn L., 2022/12/30. Antimicrobial resistance and infection control, 11 (1) p. 165. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3F2F6AB9DDC0]
 
Phagothérapie pour traiter les infections respiratoires [Phage therapy for respiratory infections]
Mitropoulou G., Gijs P.J., Koutsokera A., Sauty A., Blanchon S., Csajka C., Brunet J.F., Resch G., Guery B., Von Garnier C., 2022/11/16. Revue medicale suisse, 18 (804) pp. 2150-2156. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CCFF1CBAD0AE]
 
Clostridioides difficile infection (CDI) epidemiology and patient characteristics in Switzerland.
Kampouri E., Filippidis P., Wölfle M., Taveira A., Badinski T., Croxatto A., Galperine T., Grandbastien B., Achermann Y., Guery B., 2022/08. Infectious diseases now, 52 (5) pp. 267-272. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D9587F593507]
Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study.
Filippidis P., Kampouri E., Woelfle M., Badinski T., Croxatto A., Galperine T., Papadimitriou-Olivgeris M., Grandbastien B., Achermann Y., Guery B., 2022/06/30. Journal of clinical medicine, 11 (13) p. 3805. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_694295A9316A]
 
Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study.
Desgranges F., Tadini E., Munting A., Regina J., Filippidis P., Viala B., Karachalias E., Suttels V., Haefliger D., Kampouri E. et al., 2022/06. Journal of general internal medicine, 37 (8) pp. 1943-1952. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_284F4C167E6F]
Nouveaux antibiotiques ? Perspectives
Guery B., 2022/04/27. Revue medicale suisse, 18 (779) pp. 837-838. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_20C5C5A93F7B]
 
Impact of 2020 EUCAST criteria on meropenem prescription for the treatment of Pseudomonas aeruginosa infections: an observational study in a university hospital.
Munting A., Regina J., Damas J., Lhopitallier L., Kritikos A., Guery B., Senn L., Viala B., 2022/04. Clinical microbiology and infection, 28 (4) pp. 558-563. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9965ABB0A742]
Therapeutic drug monitoring of cefepime in a non-critically ill population: retrospective assessment and potential role for model-based dosing.
Suttels V., André P., Thoma Y., Veuve F., Decosterd L., Guery B., Buclin T., 2022/04. JAC-antimicrobial resistance, 4 (2) pp. dlac043. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F7941F21C4D1]
 
How to Manage Pseudomonas aeruginosa Infections
Papadimitriou-Olivgeris Matthaios, Jacot Damien, Guery Benoit, 2022. pp. 425-445 dans Pseudomonas aeruginosa, Springer International Publishing.
[DOI][Pmid][serval:BIB_4B03044187D4]
 
The LAUsanne STAPHylococcus aureus ENdocarditis (LAUSTAPHEN) score: A prediction score to estimate initial risk for infective endocarditis in patients with S. aureus bacteremia.
Papadimitriou-Olivgeris M., Monney P., Mueller L., Senn L., Guery B., 2022. Frontiers in cardiovascular medicine, 9 p. 961579. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F4DB85A27FDE]
2021
 
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
van Prehn J., Reigadas E., Vogelzang E.H., Bouza E., Hristea A., Guery B., Krutova M., Norén T., Allerberger F., Coia J.E. et al., 2021/12. Clinical microbiology and infection, 27 Suppl 2 pp. S1-S21. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_43AFCE133B85]
 
Infective endocarditis, is there a goal beyond antibiotics and surgery?
Guery B., Papadimitriou-Olivgeris M., 2021/12. European journal of internal medicine, 94 pp. 25-26. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5BFE282EE02A]
A prospective, observational study of fidaxomicin use for Clostridioides difficile infection in France.
Guery B., Berger P., Gauzit R., Gourdon M., Barbut F., DAFNE study group, Dafne Study Group, Bémer P., Bessède E., Camou F. et al., 2021/06. The Journal of international medical research, 49 (6) p. 3000605211021278. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8FC65075C2F5]
 
Establishment of a French surveillance system of Clostridiodes difficile infection: Comparison of patient's characteristics with other national and European data.
Khanafer N., Hemmendinger A., Guery B., Vachée A., Rogues A.M., Gravet A., Boutoille D., Vanjak D., Barbut F., Vanhems P., 2021/06. Anaerobe, 69 p. 102329. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1B5F75502AC0]
Infective endocarditis: prevention and antibiotic prophylaxis.
Sendi P., Hasse B., Frank M., Flückiger U., Boggian K., Guery B., Jeger R., Zbinden S., Agyeman P., Knirsch W. et al., 2021/02/15. Swiss medical weekly, 151 pp. w20473. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E534D19A7717]
Clostridioides difficile Infection, Still a Long Way to Go.
Kampouri E., Croxatto A., Prod'hom G., Guery B., 2021/01/20. Journal of clinical medicine, 10 (3) pp. E389. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C51251BBC303]
Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
Zimmerli A., Monti M., Fenwick C., Eckerle I., Beigelman-Aubry C., Pellaton C., Jaton K., Dumas D., Stamm G.M., Infanti L. et al., 2021. Frontiers in immunology, 12 p. 613502. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AE27E1EE2E3C]
2020
 
In the name of common sense: EUCAST breakpoints and potential pitfalls.
Meylan S., Guery B., 2020/12. Clinical microbiology and infection, 26 (12) pp. 1593-1594. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13A6BDABC04C]
 
‘In the name of common sense' – Author's reply
Meylan Sylvain, Guery Benoit, 2020/12. Clinical Microbiology and Infection, 26 (12) p. 1696.
[DOI][WoS][Pmid][serval:BIB_F78EF5A41D07]
Antibiotic-related gut dysbiosis induces lung immunodepression and worsens lung infection in mice.
Dessein R., Bauduin M., Grandjean T., Le Guern R., Figeac M., Beury D., Faure K., Faveeuw C., Guery B., Gosset P. et al., 2020/10/15. Critical care, 24 (1) p. 611. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B0E4D6B6DD9C]
 
Diagnostic and therapy of severe Clostridioides difficile infections in the ICU.
Guery B., Barbut F., Tschudin-Sutter S., 2020/10. Current opinion in critical care, 26 (5) pp. 450-458. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_01C7BF9B84B7]
Diagnostic Performance of 18F-FDG PET/CT in Native Valve Endocarditis: Systematic Review and Bivariate Meta-Analysis.
Kamani C.H., Allenbach G., Jreige M., Pavon A.G., Meyer M., Testart N., Firsova M., Fernandes Vieira V., Boughdad S., Nicod Lalonde M. et al., 2020/09/25. Diagnostics, 10 (10) p. 754. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BC3B9C2D5E75]
SARS-CoV-2, un point dans la tourmente [SARS-CoV-2, a point in the storm]
Tadini E., Papamidimitriou-Olivgeris M., Opota O., Moulin E., Lamoth F., Manuel O., Lhopitallier L., Jaton K., Croxatto A., Grandbastien B. et al., 2020/05/06. Revue medicale suisse, 16 (692) pp. 917-923. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_88A8DA997C5D]
Nouveaux antibiotiques pour la clinique : un tour d’horizon [New antibiotics for the clinical setting, an overview]
Meylan S., Portillo Tunon V., Guery B., 2020/04/15. Revue medicale suisse, 16 (690) pp. 713-718. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_18A9A4B20317]
 
Pharmacokinetic analysis of an extended-pulsed fidaxomicin regimen for the treatment of Clostridioides (Clostridium) difficile infection in patients aged 60 years and older in the EXTEND randomized controlled trial.
Guery B., Georgopali A., Karas A., Kazeem G., Michon I., Wilcox M.H., Cornely O.A., 2020/04/01. The Journal of antimicrobial chemotherapy, 75 (4) pp. 1014-1018. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DE3D1896ABDA]
Infectiologie: «less is more » [Infectious diseases : « less is more »]
Tschopp J., Guéry B., Boillat Blanco N., 2020/01/15. Revue medicale suisse, 16 (676-7) pp. 55-58. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5FB72697A251]
Predicting Venous Thromboembolic Events in Patients with Coronavirus Disease 2019 Requiring Hospitalization: an Observational Retrospective Study by the COVIDIC Initiative in a Swiss University Hospital.
Kampouri E., Filippidis P., Viala B., Méan M., Pantet O., Desgranges F., Tschopp J., Regina J., Karachalias E., Bianchi C. et al., 2020. BioMed research international, 2020 p. 9126148. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_458CAB0E5E15]
The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks.
Enaud R., Prevel R., Ciarlo E., Beaufils F., Wieërs G., Guery B., Delhaes L., 2020. Frontiers in cellular and infection microbiology, 10 p. 9. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_75403E247CE9]
Use of whole-genome sequencing in the molecular investigation of care-associated HCoV-OC43 infections in a hematopoietic stem cell transplant unit.
Beury D., Fléchon L., Maurier F., Caboche S., Varré J.S., Touzet H., Faure K., Dubuisson J., Hot D., Guery B. et al., 2020/01. Journal of clinical virology, 122 p. 104206. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E7DB575E8BE2]
2019
Microbiological Characterization and Clinical Outcomes After Extended-Pulsed Fidaxomicin Treatment for Clostridioides difficile Infection in the EXTEND Study.
Wilcox M.H., Cornely O.A., Guery B., Longshaw C., Georgopali A., Karas A., Kazeem G., Palacios-Fabrega J.A., Vehreschild MJGT, 2019/11. Open forum infectious diseases, 6 (11) pp. ofz436. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_49A5FCFA8072]
 
Clostridioides difficile: diagnosis and treatments.
Guery B., Galperine T., Barbut F., 2019/08/20. BMJ, 366 pp. l4609. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1611587D02D4]
 
Early Antimicrobial Therapy for Sepsis: Does Each Hour Really Count?
Guery B., Calandra T., 2019/08. Seminars in respiratory and critical care medicine, 40 (4) pp. 447-453. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2FF40F08C5BA]
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses.
Cornely O.A., Vehreschild MJGT, Adomakoh N., Georgopali A., Karas A., Kazeem G., Guery B., 2019/06. European journal of clinical microbiology & infectious diseases, 38 (6) pp. 1187-1194. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EDFE031C4B47]
 
Isavuconazole brain penetration in cerebral aspergillosis.
Lamoth F., Mercier T., André P., Pagani J.L., Pantet O., Maduri R., Guery B., Decosterd L.A., 2019/06/01. The Journal of antimicrobial chemotherapy, 74 (6) pp. 1751-1753. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DBC07C267A48]
 
Infectiologie sur mesure - 3. Transplantation de microbiote fécal : l’exemple du traitement de Clostridioides difficile [Customised infectiology - Fecal microbiota transplantation : following the Clostridioides difficile pathway]
Galperine T.K., Guery B., 2019/04/10. Revue medicale suisse, 15 (646) pp. 776-779. Peer-reviewed.
[Pmid][serval:BIB_3FB1130D6AA1]
 
Clostridium difficile infection trials: what is the primary endpoint?
Guery B., 2019/03. The Lancet. Infectious diseases, 19 (3) pp. 219-220. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_21E6A02CC97F]
2018
 
Rational approach in the management of Pseudomonas aeruginosa infections.
Bassetti M., Vena A., Russo A., Croxatto A., Calandra T., Guery B., 2018/12. Current opinion in infectious diseases, 31 (6) pp. 578-586. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_89903939D2F8]
 
1982. Multiplex PCR-Based Analysis of Enteric Pathogens in Faecal Samples from Patients with <i>Clostridium difficile</i> Infection in the Randomized, Controlled EXTEND Study Comparing the Efficacy of Extended-Pulsed Fidaxomicin With Vancomycin Therapy
Wilcox Mark, Cornely Oliver A, Guery Benoit, Longshaw Christopher, Georgopali Areti, Karas Andreas, Kazeem Gbenga, Palacios-Fabrega Jose Alejandro, Vehreschild Maria J G T, 2018/11/26. pp. S575-S576 dans Open Forum Infectious Diseases.
[DOI][serval:BIB_A45587670123]
 
Biomarqueurs systèmiques pour les infections respiratoires [Systemic biomarkers in respiratory tract infections]
Balmpouzis Z., Diamanti E., Kritikos A., Guery B., Nicod L.P., 2018/11/14. Revue medicale suisse, 14 (627) pp. 2074-2078. Peer-reviewed.
[Pmid][serval:BIB_1A96C57ADE75]
 
Native aortic valve endocarditis due to Pseudomonas stutzeri in a 91-year-old woman.
Héquette-Ruz R., Charpentier A., Delabriere I., Loiez C., Guery B., Puisieux F., Beuscart J.B., 2018/10. Medecine et maladies infectieuses, 48 (7) pp. 492-494. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E44F843E59BB]
 
Biphasic lung injury during Streptococcus pneumoniae infection in a murine model.
Prevotat A., Rouyer C., Gosset P., Kipnis E., Faure K., Guery B., 2018/03. Medecine et maladies infectieuses, 48 (2) pp. 103-113. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_697FEA47865B]
 
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.
Guery B., Menichetti F., Anttila V.J., Adomakoh N., Aguado J.M., Bisnauthsing K., Georgopali A., Goldenberg S.D., Karas A., Kazeem G. et al., 2018/03. The Lancet. Infectious diseases, 18 (3) pp. 296-307. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E20EA95FD4C2]
 
Exploring ways to improve CDI outcomes.
Galpérine T., Guery B., French Group of Fecal Microbiota Transplantation (GFTF), 2018/02. Medecine et maladies infectieuses, 48 (1) pp. 10-17. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D9A97DB247AF]
 
Correction to: Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.
Bruneel F., Tubach F., Mira J.P., Houze S., Gibot S., Huisse M.G., Megarbane B., Choquet C., Corne P., Peytel E. et al., 2018/01. Intensive care medicine, 44 (1) pp. 141-143. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E1A73BC3BED0]
How to manage Pseudomonas aeruginosa infections.
Bassetti M., Vena A., Croxatto A., Righi E., Guery B., 2018. Drugs in context, 7 p. 212527. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_91C5DC48B249]
2017
 
Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
Robin C., Héquette-Ruz R., Guery B., Boyle E., Herbaux C., Galperine T., 2017/12. Medecine et maladies infectieuses, 47 (8) pp. 532-539. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AA7184D0F60D]
 
Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital.
Pichenot M., Héquette-Ruz R., Le Guern R., Grandbastien B., Charlet C., Wallet F., Schiettecatte S., Loeuillet F., Guery B., Galperine T., 2017/08. Infection, 45 (4) pp. 425-431. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4F4DFAB1200E]
 
The human NAIP-NLRC4-inflammasome senses the Pseudomonas aeruginosa T3SS inner-rod protein.
Grandjean T., Boucher A., Thepaut M., Monlezun L., Guery B., Faudry E., Kipnis E., Dessein R., 2017/08/01. International immunology, 29 (8) pp. 377-384. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B66F2575F681]
 
A Pseudomonas aeruginosa TIR effector mediates immune evasion by targeting UBAP1 and TLR adaptors.
Imbert P.R., Louche A., Luizet J.B., Grandjean T., Bigot S., Wood T.E., Gagné S., Blanco A., Wunderley L., Terradot L. et al., 2017/07/03. The EMBO journal, 36 (13) pp. 1869-1887. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BCF5726811CC]
 
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.
Charlier C., Perrodeau É., Leclercq A., Cazenave B., Pilmis B., Henry B., Lopes A., Maury M.M., Moura A., Goffinet F. et al., 2017/05. The Lancet. Infectious diseases, 17 (5) pp. 510-519. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C153FD89C631]
 
Fecal Microbiota Transplantation: Do We Need Harmonization?
Galpérine T., Sokol H., Guery B., 2017/05/01. Clinical infectious diseases, 64 (9) p. 1292. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_56B3C177C24B]
 
Is a chlorine dioxide wiping procedure suitable for the high-level disinfection of nasendoscopes?
Henoun Loukili N., Lemaitre N., Guery B., Gaillot O., Chevalier D., Mortuaire G., 2017/03. Journal of infection prevention, 18 (2) pp. 78-83. Peer-reviewed.
[DOI][Pmid][serval:BIB_DEA80FD780EE]
 
Proposal for shorter antibiotic therapies.
Wintenberger C., Guery B., Bonnet E., Castan B., Cohen R., Diamantis S., Lesprit P., Maulin L., Péan Y., Peju E. et al., 2017/03. Medecine et maladies infectieuses, 47 (2) pp. 92-141. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1BDB3EAC03A2]
 
Haemophilus parainfluenzae endocarditis in young adults.
Faure E., Cannesson O., Schurtz G., Coisne A., Vincentelli A., Faure K., Guery B., 2017/02. Medecine et maladies infectieuses, 47 (1) pp. 58-60. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FCEFA4E2A85F]
 
The aliphatic amidase AmiE is involved in regulation of Pseudomonas aeruginosa virulence.
Clamens T., Rosay T., Crépin A., Grandjean T., Kentache T., Hardouin J., Bortolotti P., Neidig A., Mooij M., Hillion M. et al., 2017/01/24. Scientific reports, 7 p. 41178. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1923CE3245FD]
Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France.
Baro E., Galperine T., Denies F., Lannoy D., Lenne X., Odou P., Guery B., Dervaux B., 2017. PloS one, 12 (1) pp. e0170258. Peer-reviewed.
[DOI][Pmid][serval:BIB_7215B307C47D]
Multidrug resistant (or antimicrobial-resistant) pathogens - alternatives to new antibiotics?
Brunel A.S., Guery B., 2017. Swiss medical weekly, 147 pp. w14553. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3D3C4EDEAE76]
2016
 
Inhibition of the Injectisome and Flagellar Type III Secretion Systems by INP1855 Impairs Pseudomonas aeruginosa Pathogenicity and Inflammasome Activation.
Anantharajah A., Faure E., Buyck J.M., Sundin C., Lindmark T., Mecsas J., Yahr T.L., Tulkens P.M., Mingeot-Leclercq M.P., Guery B. et al., 2016/10/01. The Journal of infectious diseases, 214 (7) pp. 1105-1116. Peer-reviewed.
[DOI][Pmid][serval:BIB_03A011CC0AD8]
 
Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.
Bortolotti P., Hennart B., Thieffry C., Jausions G., Faure E., Grandjean T., Thepaut M., Dessein R., Allorge D., Guery B.P. et al., 2016/07/08. BMC microbiology, 16 (1) p. 137. Peer-reviewed.
[DOI][Pmid][serval:BIB_9AF1332A33CD]
 
Cefoxitin: An alternative to carbapenems in urinary tract infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Mambie A., Vuotto F., Poitrenaud D., Weyrich P., Cannesson O., Dessein R., Faure K., Guery B., Galpérine T., 2016/06. Medecine et maladies infectieuses, 46 (4) pp. 215-219. Peer-reviewed.
[DOI][Pmid][serval:BIB_22D46DF377D1]
 
IST-05 - Un spirochète peut en cacher un autre
Cannesson O., Hecquette Ruz R., Filali A., Mambie A., Poitrenaud D., Leguern A., Faure E., Douaud M., Faure K., Guery B., 2016/06., 17es Journées Nationales d’Infectiologie p. 73 dans Médecine et Maladies Infectieuses.
[DOI][serval:BIB_B3924659445D]
 
Recommandations du bon usage des antibiotiques : améliorer les pratiques médicales et non assujettir les infectiologues [Antimicrobial stewardship policy: Improve the quality of medical practices and not subject the infectious diseases specialists]
Roger P.M., Leroy J., Garrait V., Guery B., 2016/05. Medecine et maladies infectieuses, 46 (3) pp. 115-116. Peer-reviewed.
[DOI][Pmid][serval:BIB_A21153ABD300]
Neither Neoplasia Nor Tuberculosis, but Francisella.
Mambie A., Wallet F., Scherman L., Armand S., Vervelle C., Faure K., Guery B., Titécat M., Loïez C., 2016/04. Open forum infectious diseases, 3 (2) pp. ofw080. Peer-reviewed.
[DOI][Pmid][serval:BIB_080CE61EA24E]
 
Antiviral therapy of primary cytomegalovirus infection with vascular thrombosis in immunocompetent adults.
Deconinck L., Flateau C., Pichenot M., Morell-Dubois S., Maillard H., Hatron P.Y., Guery B., Faure K., 2016/03. Medecine et maladies infectieuses, 46 (2) pp. 87-92. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4155C8E0D5D5]
 
Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation.
Sokol H., Galperine T., Kapel N., Bourlioux P., Seksik P., Barbut F., Scanzi J., Chast F., Batista R., Joly F. et al., 2016/03. Digestive and liver disease, 48 (3) pp. 242-247. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4BCA770372A6]
 
Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways.
Faure E., Bortolotti P., Kipnis E., Faure K., Guery B., 2016/01/13. Journal of visualized experiments 107 pp. e53218. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E5FA8EF212A2]
2015
 
Diguanylate cyclase DgcP is involved in plant and human Pseudomonas spp. infections.
Aragon I.M., Pérez-Mendoza D., Moscoso J.A., Faure E., Guery B., Gallegos M.T., Filloux A., Ramos C., 2015/11. Environmental microbiology, 17 (11) pp. 4332-4351. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B6937D53A3EF]
 
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.
Lanternier F., Poiree S., Elie C., Garcia-Hermoso D., Bakouboula P., Sitbon K., Herbrecht R., Wolff M., Ribaud P., Lortholary O. et al., 2015/11. The Journal of antimicrobial chemotherapy, 70 (11) pp. 3116-3123. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_398DCBCD3BCB]
 
Correlation between cytotoxicity induced by Pseudomonas aeruginosa clinical isolates from acute infections and IL-1β secretion in a model of human THP-1 monocytes.
Anantharajah A., Buyck J.M., Faure E., Glupczynski Y., Rodriguez-Villalobos H., De Vos D., Pirnay J.P., Bilocq F., Guery B., Tulkens P.M. et al., 2015/10. Pathogens and disease, 73 (7). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B166B70505DE]
 
Protective role of murine norovirus against Pseudomonas aeruginosa acute pneumonia.
Thépaut M., Grandjean T., Hober D., Lobert P.E., Bortolotti P., Faure K., Dessein R., Kipnis E., Guery B., 2015/09/04. Veterinary research, 46 (1) p. 91. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_237C7D7FFF6F]
 
Journée européenne sur les antibiotiques: quoi de neuf en France? [European Antibiotic Awareness Day: What is new in France?]
Pulcini C., Alfandari S., Ballereau F., Bonnet E., Bruneel F., Castan B., Chidiac C., Cohen R., Descamps D., Doco-Lecompte T. et al., 2015/09. Medecine et maladies infectieuses, 45 (9) pp. 345-347. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6FB4824DB1F4]
 
Extensive Inflammatory Gingival Tumor in a Young Nonsmoking Woman: Back to Basics.
Hajji F., Beraud G., Genay A., Raoul G., Faure K., Guery B., Ferri J., 2015/07. The Journal of craniofacial surgery, 26 (5) pp. e388-90. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2E9AE65DDAE6]
Preparedness of healthcare workers at French Ebola referral centres.
Tarantini C., Peretti-Watel P., Yazdanpana Y., Guery B., Chidiac C., Rapp C., Brouqui P., 2015/07. New microbes and new infections, 6 pp. 40-41. Peer-reviewed.
[DOI][Pmid][serval:BIB_96EE9ED6FD88]
 
Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).
Bretonnière C., Leone M., Milési C., Allaouchiche B., Armand-Lefevre L., Baldesi O., Bouadma L., Decré D., Figueiredo S., Gauzit R. et al., 2015/07. Intensive care medicine, 41 (7) pp. 1181-1196. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_995893567B02]
 
Molecular identification of Mucorales in human tissues: contribution of PCR electrospray-ionization mass spectrometry.
Alanio A., Garcia-Hermoso D., Mercier-Delarue S., Lanternier F., Gits-Muselli M., Menotti J., Denis B., Bergeron A., Legrand M., Lortholary O. et al., 2015/06. Clinical microbiology and infection, 21 (6) pp. 594.e1-5. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FD8BDFD69970]
 
Transplantation de microbiote fécal dans le cadre des infections à Clostridium difficile récidivantes : recommandations pour la pratique clinique courante [Fecal microbiota transplantation for treatment of relapsing Clostridium difficile infection: Guidelines for clinical practice].
Sokol H., Galperine T., Kapel N., Bourlioux P., Seksik P., Barbut F., Scanzi J., Chast F., Batista R., Joly F. et al., 2015/04. Hepato-Gastro, 22 (4) pp. 278-290.
[DOI][serval:BIB_192DAA9F7285]
 
Corrigendum to “Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases'' [J. Clin. Virol. 61 (2014) 275–278]
Poissy J., Goffard A., Parmentier-Decrucq E., Favory R., Kauv M., Kipnis E., Mathieu D., van der Werf S., Guery B., The MERS-CoV Biology Group, 2015/02. Journal of Clinical Virology, 63 p. 94.
[DOI][WoS][serval:BIB_3CC0DB6E10B0]
 
Prise en charge des infections à Clostridium difficile du sujet âgé : état des lieux en 2014 [Clostridium difficile infection in the elderly: an update].
Hequette-Ruz R., Paccalin M., Guery B., 2015/02. Revue de Geriatrie, 40 (2) pp. 85-92.
[serval:BIB_24A6C386A247]
 
Ebola et autres, ces virus venus d’ailleurs [Ebola and others, those viruses coming from far away]
Guery B., Grandbastien B., Galpérine T., Faure K., 2015. Reanimation, 24 (Suppl 2) pp. 379-385. Peer-reviewed.
[DOI][Pmid][serval:BIB_FD8A2A326AA7]
 
World alliance against antibiotic resistance: The WAAAR declaration against antibiotic resistance. [Alianza Mundial contra la resistencia antibiótica. Declaración contra la resistencia antibiótica]
Carlet J., Members of the WAAAR, 2015. Medicina intensiva, 39 (1) pp. 34-39. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F982734D7147]
2014
 
Antiadhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection.
Boukerb A.M., Rousset A., Galanos N., Méar J.B., Thépaut M., Grandjean T., Gillon E., Cecioni S., Abderrahmen C., Faure K. et al., 2014/12/26. Journal of medicinal chemistry, 57 (24) pp. 10275-10289. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4F306C4A65C5]
 
Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases.
Poissy J., Goffard A., Parmentier-Decrucq E., Favory R., Kauv M., Kipnis E., Mathieu D., van der Werf S., Guery B., MERS-CoV Biology Group, 2014/10. Journal of clinical virology, 61 (2) pp. 275-278. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C92520CA6240]
 
Stratégies de réduction de l'utilisation des antibiotiques à visée curative en réanimation (adulte et pédiatrique)
Bédos Jean-Pierre, Allaouchiche Bernard, Armand-Lefèvre Laurence, Baldesi Olivier, Bouadma Lila, Decré Dominique, Figueiredo Samy, Gauzit Rémy, Guery Benoit, Joram Nicolas et al., 2014/09. Réanimation, 23 (5) pp. 558-582.
[DOI][serval:BIB_2F0FAD2F848D]
 
Scavenging of reactive oxygen species by tryptophan metabolites helps Pseudomonas aeruginosa escape neutrophil killing.
Genestet C., Le Gouellec A., Chaker H., Polack B., Guery B., Toussaint B., Stasia M.J., 2014/08. Free radical biology & medicine, 73 pp. 400-410. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0A6007EAF708]
 
Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab.
Heusele M., Clerson P., Guery B., Lambert M., Launay D., Lefevre G., Morell-Dubois S., Maillard H., Le Gouellec N., Hatron P.Y. et al., 2014/06. Clinical rheumatology, 33 (6) pp. 799-805. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_617BBA0072B5]
 
U-08: Gestion des infections à MERS-CoV : expérience au CHRU de Lille
Ducourant C., gerves C., Pichenot M., Maerten C., Grandbastien B., Guery B., Serniclay C., 2014/06., 15es Journées Nationales d’Infectiologie p. 103 dans Médecine et Maladies Infectieuses.
[DOI][serval:BIB_85DAFB2E726B]
 
Autoimmune N-methyl-D-aspartate receptor encephalitis is a differential diagnosis of infectious encephalitis.
Thomas L., Mailles A., Desestret V., Ducray F., Mathias E., Rogemond V., Didelot A., Marignier S., Stahl J.P., Honnorat J. et al., 2014/05. The Journal of infection, 68 (5) pp. 419-425. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1CE8A7627E9F]
 
Comment traiter une infection digestive à Clostridium difficile en 2014 ?
Barbut F., Guery B., Eckert C., 2014/05. Réanimation, 23 (3) pp. 284-297.
[DOI][serval:BIB_BEF81F484B52]
 
Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome.
Faure E., Mear J.B., Faure K., Normand S., Couturier-Maillard A., Grandjean T., Balloy V., Ryffel B., Dessein R., Chignard M. et al., 2014/04/01. American journal of respiratory and critical care medicine, 189 (7) pp. 799-811. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F223D3BBE3FF]
 
European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection.
Debast S.B., Bauer M.P., Kuijper E.J., European Society of Clinical Microbiology and Infectious Diseases, 2014/03. Clinical microbiology and infection, 20 (Suppl 2) pp. 1-26. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_25B403FB9E82]
 
Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal response.
Mear J.B., Gosset P., Kipnis E., Faure E., Dessein R., Jawhara S., Fradin C., Faure K., Poulain D., Sendid B. et al., 2014/01. Infection and immunity, 82 (1) pp. 306-315. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BCA98D475C71]
 
Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?
Faure E., Poissy J., Goffard A., Fournier C., Kipnis E., Titecat M., Bortolotti P., Martinez L., Dubucquoi S., Dessein R. et al., 2014. PloS one, 9 (2) pp. e88716. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13573EA8BA6B]
2013
 
State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans.
Who Mers-Cov Research Group, Guery B., 2013/11/12. PLoS currents, 5. Peer-reviewed.
[DOI][Pmid][serval:BIB_CE4726FB694A]
 
Epidemiology of infectious encephalitis, differences between a prospective study and hospital discharge data.
Bernard S., Mailles A., Stahl J.P., Steering Committee and Investigators Group, 2013/11. Epidemiology and infection, 141 (11) pp. 2256-2268. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DEC5106226D1]
 
Coronavirus: need for a therapeutic approach.
Guery B., van der Werf S., 2013/09. The Lancet. Infectious diseases, 13 (9) pp. 726-727. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7EA9905D87EE]
 
Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission.
Guery B., Poissy J., el Mansouf L., Séjourné C., Ettahar N., Lemaire X., Vuotto F., Goffard A., Behillil S., Enouf V. et al., 2013/06/29. Lancet, 381 (9885) pp. 2265-2272. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8127E24045E3]
 
First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013.
Mailles A., Blanckaert K., Chaud P., van der Werf S., Lina B., Caro V., Campese C., Guéry B., Prouvost H., Lemaire X. et al., 2013/06/13. Euro surveillance, 18 (24). Peer-reviewed.
[Pmid][serval:BIB_DB14AFF4F638]
 
Encephalitis due to Mycobacterium tuberculosis in France.
Honnorat E., De Broucker T., Mailles A., Stahl J.P., le comité de pilotage et groupe des investigateurs, 2013/06. Medecine et maladies infectieuses, 43 (6) pp. 230-238. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_88E1E2A8B2D1]
 
Candida albicans and Pseudomonas aeruginosa interactions: more than an opportunistic criminal association?
Méar J.B., Kipnis E., Faure E., Dessein R., Schurtz G., Faure K., Guery B., 2013/04. Medecine et maladies infectieuses, 43 (4) pp. 146-151. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9757D8D0CF8E]
 
Vaccinal status of healthcare students in Lille.
Faure E., Cortot C., Gosset D., Cordonnier A., Deruelle P., Guery B., 2013/03. Medecine et maladies infectieuses, 43 (3) pp. 114-117. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6B216A31C400]
 
First case of cerebral abscess due to a novel Nocardia species in an immunocompromised patient
Flateau C., Jurado V., Lemaitre N., Loiez C., Wallet F., Saiz-Jimenez C., Decoene C., Bergeron E., Boiron P., Faure K. et al., 2013/02. J Clin Microbiol, 51 (2) pp. 696-700.
[DOI][Pmid][serval:BIB_52E9D7FD0A70]
 
Pneumonie à Nocardia pseudobrasiliensis chez un patient transplanté cardiaque [Nocardia pseudobrasiliensis pneumonia in a heart transplant recipient]
Harent S., Vuotto F., Wallet F., Flateau C., Chopin M.C., Faure K., Guery B., 2013/02. Medecine et maladies infectieuses, 43 (2) pp. 85-87. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_93066C22E186]
 
P. aeruginosa LPS stimulates calcium signaling and chloride secretion via CFTR in human bronchial epithelial cells.
Buyck J.M., Verriere V., Benmahdi R., Higgins G., Guery B., Matran R., Harvey B.J., Faure K., Urbach V., 2013/01. Journal of cystic fibrosis, 12 (1) pp. 60-67. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BBC62322FF9B]
2012
 
Factors associated with recurrence of catheter-related bloodstream infections in home parenteral nutrition patients.
Béraud G., Seguy D., Alfandari S., Lenne X., Leburgue F., Faure K., Guery B., 2012/11. European journal of clinical microbiology & infectious diseases, 31 (11) pp. 2929-2933. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F33DB0D6805A]
 
Alliance contre les bactéries multirésistantes : sauvons les antibiotiques ! [Alliance against MDRO: safeguarding antibiotics]
Carlet J., Rambaud C., Pulcini C., l'Alliance contre développement des bactéries multirésistantes (ACdeBMR), 2012/09. Annales francaises d'anesthesie et de reanimation, 31 (9) pp. 704-708. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D921ADF638DD]
 
Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients.
De Broucker T., Mailles A., Chabrier S., Morand P., Stahl J.P., steering committee and investigators group, 2012/08. Clinical microbiology and infection, 18 (8) pp. 808-819. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_167F0E045410]
 
Les thérapeutiques anti-infectieuses non antibiotiques
Kipnis É., Dessein R., Faure K., Guery B., 2012/05. Réanimation, 21 (3) pp. 303-316.
[DOI][serval:BIB_FF498AEE084E]
 
Long-term outcome of patients presenting with acute infectious encephalitis of various causes in France.
Mailles A., De Broucker T., Costanzo P., Martinez-Almoyna L., Vaillant V., Stahl J.P., Steering Committee and Investigators Group, 2012/05. Clinical infectious diseases, 54 (10) pp. 1455-1464. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_55CB700EC9BC]
 
Point prevalence survey of antibiotic use in French hospitals in 2009.
Robert J., Péan Y., Varon E., Bru J.P., Bedos J.P., Bertrand X., Lepape A., Stahl J.P., Gauzit R., Société de pathologie infectieuse de langue française (SPILF) et al., 2012/04. The Journal of antimicrobial chemotherapy, 67 (4) pp. 1020-1026. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4F52C7C9748A]
 
Céfoxitine et BLSE [Cefoxitin and ESBL]
Boyer M., Bignon A., Dessein R., Faure K., Guery B., Kipnis E., 2012/03. Medecine et maladies infectieuses, 42 (3) pp. 126-128. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F813C8E8ED2B]
 
Herpes simplex encephalitis and management of acyclovir in encephalitis patients in France.
Stahl J.P., Mailles A., De Broucker T., Steering Committee and Investigators Group, 2012/02. Epidemiology and infection, 140 (2) pp. 372-381. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A4D89D0EFD7F]
2011
 
Fungal aero-decontamination efficacy of mobile air-treatment systems.
Fréalle E., Lestrez C., Skierlak T., Melboucy D., Guery B., Durand-Joly I., Delhaes L., Loukili N., 2011/11. Medical mycology, 49 (8) pp. 825-833. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_06A2C404FCE5]
 
Listeria monocytogenes encephalitis in France.
Mailles A., Lecuit M., Goulet V., Leclercq A., Stahl J.P., National Study on Listeriosis Encephalitis Steering Committee, 2011/11. Medecine et maladies infectieuses, 41 (11) pp. 594-601. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_545F499CFD29]
 
Beta-adrenergic modulation of lung fluid balance in acute P aeruginosa pneumonia in rats.
Robriquet L., Kipnis E., Guery B., 2011/10. Experimental lung research, 37 (8) pp. 453-460. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_148D3674AA8C]
 
Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia.
Le Berre R., Nguyen S., Nowak E., Kipnis E., Pierre M., Quenee L., Ader F., Lancel S., Courcol R., Guery B.P. et al., 2011/09. Critical care medicine, 39 (9) pp. 2113-2120. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_768F955CD1E1]
 
Halte à la résistance: sauvons les antibiotiques [Stop bacterial resistance: save antibiotics]
Carlet J., le groupe Alliance francophone contre le développement des bactéries multi-résistantes aux antibiotiques (AC-2-BMR), 2011/07. Medecine et maladies infectieuses, 41 (7) pp. 351-352. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BF84325CDA03]
 
Tout part de Greenwich… [Weight loss and dyspnea in a 46-year-old woman]
Stavris C., Lambert M., Lefèvre G., Mirault T., Pape E., Buchdahl-Duchange A.L., Maillard-Lefebvre H., Sivova N., Morell-Dubois S., Launay D. et al., 2011/07. La Revue de medecine interne, 32 (7) pp. 447-450. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9AB93D6BEAE3]
 
Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model.
Ader F., Jawhara S., Nseir S., Kipnis E., Faure K., Vuotto F., Chemani C., Sendid B., Poulain D., Guery B., 2011/06/20. Critical care, 15 (3) pp. R150. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DF7A6C114806]
 
Vascular nosocomial Nocardia farcinica infection after arterial stenting in an immunocompetent patient.
Vuotto F., Faure K., Queyre V., Dessein R., Pasquet A., Lambert M., Haulon S., Beregi J., Guery B., Hatron P., 2011. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 22 (1) pp. e10-1. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_359DF70D2C76]
2010
 
Infections à bactéries à Gram positif: quoi de plus en 2010? [Infections with Gram-positive bacteria: what's new in 2010?]
Wintenberger C., Guery B., 2010/12. Medecine et maladies infectieuses, 40 (12) pp. 724-729. Peer-reviewed.
[DOI][Pmid][serval:BIB_C334374389A3]
 
Réévaluation de la colistine
Kipnis É., Guery B.-P., 2010/12. Antibiotiques, 12 (4) pp. 205-227.
[DOI][WoS][serval:BIB_DA010FF6E669]
 
Severe imported falciparum malaria: a cohort study in 400 critically ill adults.
Bruneel F., Tubach F., Corne P., Megarbane B., Mira J.P., Peytel E., Camus C., Schortgen F., Azoulay E., Cohen Y. et al., 2010/10/08. PloS one, 5 (10) pp. e13236. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7247EC43B7EA]
 
Chapter 1. Introduction. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster.
Sprung C.L., Cohen R., Adini B., European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster, 2010/04. Intensive care medicine, 36 (Suppl 1) pp. S4-10. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3BA48CF92134]
 
Chapter 2. Surge capacity and infrastructure considerations for mass critical care. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster.
Hick J.L., Christian M.D., Sprung C.L., European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster, 2010/04. Intensive care medicine, 36 (Suppl 1) pp. S11-20. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7C8DC2BA39C8]
 
Chapter 3. Coordination and collaboration with interface units. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster.
Joynt G.M., Loo S., Taylor B.L., Margalit G., Christian M.D., Sandrock C., Danis M., Leoniv Y., Sprung C.L., European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster, 2010/04. Intensive care medicine, 36 (Suppl 1) pp. S21-31. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_52DA44454779]
 
Chapter 4. Manpower. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster.
Sandrock C., European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster, 2010/04. Intensive care medicine, 36 (Suppl 1) pp. S32-7. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F318C0759E4F]
 
Chapter 5. Essential equipment, pharmaceuticals and supplies. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster.
Sprung C.L., Kesecioglu J., European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster, 2010/04. Intensive care medicine, 36 (Suppl 1) pp. S38-44. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B6A312FC2A71]
 
Chapter 6. Protection of patients and staff during a pandemic. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster.
Taylor B.L., Montgomery H.E., Rhodes A., Sprung C.L., European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster, 2010/04. Intensive care medicine, 36 (Suppl 1) pp. S45-54. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A456A6BF5135]
 
Chapter 7. Critical care triage. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster.
Christian M.D., Joynt G.M., Hick J.L., Colvin J., Danis M., Sprung C.L., European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster, 2010/04. Intensive care medicine, 36 (Suppl 1) pp. S55-64. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FD3FE638DEE6]
 
Chapter 8. Medical procedures. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster.
Zimmerman J.L., Sprung C.L., European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster, 2010/04. Intensive care medicine, 36 (Suppl 1) pp. S65-9. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0882BEF1AF29]
 
Chapter 9. Educational process. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster.
Richards G.A., Sprung C.L., European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster, 2010/04. Intensive care medicine, 36 (Suppl 1) pp. S70-9. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B563921B9D48]
2009
 
Le doripénème: quelle place pour un nouveau carbapénème? [Doripenem: need for a new carbapenem]
Guery B.P., 2009/12. Medecine et maladies infectieuses, 39 (12) pp. 871-876. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BE16AB9FFE43]
 
Faut-il mettre un interne en infectiologie transversale ? L'expérience au centre hospitalier régional et universitaire de Lille [Could a resident be a remote infectious disease specialist consultant? The Lille teaching hospital experience]
Vuotto F., Prevotat A., Beraud G., Hembert K., Faure K., Alfandari S., Guery B., 2009/11. Medecine et maladies infectieuses, 39 (11) pp. 864-866. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_610EA9405382]
 
Recommandations de pratique clinique. Infections ostéo-articulaires sur matériel (prothèse, implant, ostéo-synthèse) [Clinical practice recommendations. Osteoarticular infections on materials (prosthesis, implant, osteosynthesis]
la Société de Pathologie Infectieuse de Langue Française (SPILF), Collège des Universitaires de Maladies Infectieuses et Tropicales (CMIT), Groupe de Pathologie Infectieuse Pédiatrique (GPIP), Société Française d'Anesthésie et de Réanimation (SFAR), Société Française de Chirurgie Orthopédique et Traumatologique (SOFCOT), Société Française d'Hygiène Hospitalière (SFHH), Société Française de Médecine Nucléaire (SFMN), Société Française de Médecine Physique et de Réadaptation (SOFMER), Société Française de Microbiologie (SFM), Société Française de Radiologie (SFR-Rad) et al., 2009/11. Medecine et maladies infectieuses, 39 (11) pp. 815-863. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4A4F15859101]
 
Recommandations de pratique clinique. Infections ostéo-articulaires sur matériel (prothèse, implant, ostéosynthèse) [Recommendations for clinical practice. Osteo-articular infection therapy according to materials used (prosthesis, implants, osteosynthesis)]
Société de Pathologie Infectieuse de Langue Française (SPILF), Collège des Universitaires de Maladies Infectieuses et Tropicales (CMIT), Groupe de Pathologie Infectieuse Pédiatrique (GPIP), Société Française d'Anesthésie et de Réanimation (SFAR), Société Française de Chirurgie Orthopédique et Traumatologique (SOFCOT), Société Française d'Hygiène Hospitalière (SFHH), Société Française de Médecine Nucléaire (SFMN), Société Française de Médecine Physique et de Réadaptation (SOFMER), Société Française de Microbiologie (SFM), Société Française de Radiologie (SFR-Rad) et al., 2009/10. Medecine et maladies infectieuses, 39 (10) pp. 745-774. Peer-reviewed.
[DOI][Pmid][serval:BIB_B892B52EEAD2]
 
Prise en charge des méningites bactériennes aiguës communautaires (a l'exclusion du nouveau-ne) Texte court - novembe 2008 [Management of acute community-acquired bacterial meningitides, except in newborn infants. Short text. November 2008. Société de Pathologie Infectieuse de Langue Française]
Société de Pathologie Infectieuse de Langue Française, Collège des Universitaires des Maladies Infectieuses et Tropicales (CMIT), Association Pédagogique Nationale pour l'Enseignement de la Thérapeutique (APNET), Société Française de Microbiologie (SFM), Société Française de Médecine d'Urgence (SFMU), Société Française de Neurologie (SFN), Société Française d'ORL (SFORL), Société Française de Pédiatrie (SFP), Société Nationale Française de Médecine Interne (SNFMI), Société de Réanimation de Langue Française (SRLF) et al., 2009/09. Revue neurologique, 165 Spec No 3 pp. F205-16. Peer-reviewed.
[Pmid][serval:BIB_4AE1D3E4D2A2]
 
Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
De Cock E., Sorensen S., Levrat F., Besnier J.M., Dupon M., Guery B., Duttagupta S., 2009/05. Medecine et maladies infectieuses, 39 (5) pp. 330-340. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7F9BB164F84F]
 
FITC-albumin as a marker for assessment of endothelial permeability in mice: comparison with 125I-albumin.
Boutoille D., Marechal X., Pichenot M., Chemani C., Guery B., Faure K., 2009/05. Experimental lung research, 35 (4) pp. 263-271. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1B84A5301DD3]
 
Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands.
Chemani C., Imberty A., de Bentzmann S., Pierre M., Wimmerová M., Guery B.P., Faure K., 2009/05. Infection and immunity, 77 (5) pp. 2065-2075. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B1911C3A756A]
 
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment.
Guery B.P., Arendrup M.C., Auzinger G., Azoulay E., Borges Sá M., Johnson E.M., Müller E., Putensen C., Rotstein C., Sganga G. et al., 2009/02. Intensive care medicine, 35 (2) pp. 206-214. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7E19BA428430]
 
Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection.
Tiesset H., Pierre M., Desseyn J.L., Guéry B., Beermann C., Galabert C., Gottrand F., Husson M.O., 2009/01. The Journal of nutrition, 139 (1) pp. 82-89. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C3889370C212]
 
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis.
Guery B.P., Arendrup M.C., Auzinger G., Azoulay E., Borges Sá M., Johnson E.M., Müller E., Putensen C., Rotstein C., Sganga G. et al., 2009/01. Intensive care medicine, 35 (1) pp. 55-62. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E2F6DCB40AD6]
 
Recurrent bacteremia, a complication of cyanoacrylate injection for variceal bleeding: report of two cases and review of the literature.
Galperine T., Flateau C., Venon M.D., Lescure F.X., Béraud G., Said Ibrahim T., Delisle F., Durand F., Faure K., Pialoux G. et al., 2009. Case reports in medicine, 2009 p. 407053. Peer-reviewed.
[DOI][Pmid][serval:BIB_C9EC5FD33601]
2008
 
Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan.
Sendid B., Dotan N., Nseir S., Savaux C., Vandewalle P., Standaert A., Zerimech F., Guery B.P., Dukler A., Colombel J.F. et al., 2008/12. Clinical and vaccine immunology, 15 (12) pp. 1868-1877. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_955C2F177B33]
 
Organisation de la réanimation en situation de pandémie de grippe aviaire [Organization of intensive care in situation of avian flu pandemic]
Guery B., Guidet B., Beloucif S., Floret D., Legall C., Montravers P., Chouaid C., Jarreau P.H., Régnier B., 2008/12. Archives de pediatrie, 15 (12) pp. 1781-1793. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C2DC001CD9E5]
 
Liste informatisée et épidémie de bactéries multirésistantes [Computerized list and multiresistant bacteria epidemic]
Guery B., Grandbastien B., Rabaud C., 2008/11. Medecine et maladies infectieuses, 38 (11) pp. 564-565. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A4C66E7828C4]
 
A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock.
Boussekey N., Chiche A., Faure K., Devos P., Guery B., d'Escrivan T., Georges H., Leroy O., 2008/09. Intensive care medicine, 34 (9) pp. 1646-1653. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8273D47D2960]
 
In vivo effect of adhesion inhibitor heparin on Legionella pneumophila pathogenesis in a murine pneumonia model.
Ader F., Le Berre R., Fackeure R., Raze D., Menozzi F.D., Viget N., Faure K., Kipnis E., Guery B., Jarraud S. et al., 2008/08. Intensive care medicine, 34 (8) pp. 1511-1519. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B2E5A7F3BE4D]
 
Cinétique d'expression des gènes de virulence de Pseudomonas aeruginosa au cours d'une infection pulmonaire chronique dans le modèle murin [Kinetics of Pseudomonas aeruginosa virulence gene expression during chronic lung infection in the murine model]
Pierre M., Le Berre R., Tiesset H., Faure K., Guery B., Desseyn J.L., Galabert C., Béghin L., Beermann C., Gottrand F. et al., 2008/06. Medecine et maladies infectieuses, 38 (6) pp. 318-323. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2EF7BED496E5]
 
Interaction de Pseudomonas aeruginosa avec Candida albicans dans les voies respiratoires: de la physiopathologie à une perspective thérapeutique [Pseudomonas aeruginosa and Candida albicans interaction in the respiratory tract: from pathophysiology to a therapeutic perspective]
Ader F., Faure K., Guery B., Nseir S., 2008/05. Pathologie-biologie, 56 (3) pp. 164-169. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F5987EBCB51A]
 
Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa.
Le Berre R., Nguyen S., Nowak E., Kipnis E., Pierre M., Ader F., Courcol R., Guery B.P., Faure K., Pyopneumagen Group, 2008/04. Clinical microbiology and infection, 14 (4) pp. 337-343. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_56CA4BFD5F72]
 
Organisation de la réanimation en situation de pandémie de grippe aviaire [The organisation of intensive care in a situation of pandemic avian influenza]
Guery B., Guidet B., Beloucif S., Floret D., Le Gall C., Montravers P., Chouaid C., Jarreau P.H., Régnier B., 2008/02. Revue des maladies respiratoires, 25 (2) pp. 223-235. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D1C07EC17F5B]
 
Identification of biofilm-associated cluster (bac) in Pseudomonas aeruginosa involved in biofilm formation and virulence.
Macé C., Seyer D., Chemani C., Cosette P., Di-Martino P., Guery B., Filloux A., Fontaine M., Molle V., Junter G.A. et al., 2008. PloS one, 3 (12) pp. e3897. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D0ABC4A2B3BC]
 
Monocyte deactivation in neutropenic acute respiratory distress syndrome patients treated with granulocyte colony-stimulating factor.
Mokart D., Kipnis E., Guerre-Berthelot P., Vey N., Capo C., Sannini A., Brun J.P., Blache J.L., Mege J.L., Blaise D. et al., 2008. Critical care, 12 (1) pp. R17. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CE3C7B882575]
2007
 
Organisation de la réanimation en situation de pandémie de grippe aviaire [Organization of intensive care units, in case of pandemic avian flu]
Guery B., Guidet B., Beloucif S., Floret D., LeGall C., Montravers P., Chouaid C., Jarreau P.H., Régnier B., Société de pathologie infectieuse de langue française et al., 2007/12. Medecine et maladies infectieuses, 37 Suppl 3 pp. S194-203. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B19ACEF2EE40]
 
Promises and limitations of the bronchoscopic microsampling probe.
Kipnis E., Guery B., Wiener-Kronish J., 2007/10. Chest, 132 (4) p. 1414. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_75AFE7CE7126]
 
Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats.
Tillie-Leblond I., Gosset P., Le Berre R., Janin A., Prangère T., Tonnel A.B., Guery B.P., 2007/07. The European respiratory journal, 30 (1) pp. 31-39. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8A1D2F5B19F5]
 
Dietary n-3 fatty acids have suppressive effects on mucin upregulation in mice infected with Pseudomonas aeruginosa.
Tetaert D., Pierre M., Demeyer D., Husson M.O., Béghin L., Galabert C., Gottrand F., Beermann C., Guery B., Desseyn J.L., 2007/06/05. Respiratory research, 8 (1) p. 39. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_556F3D9D9BE7]
 
Omega-3 polyunsaturated fatty acids improve host response in chronic Pseudomonas aeruginosa lung infection in mice.
Pierre M., Husson M.O., Le Berre R., Desseyn J.L., Galabert C., Béghin L., Beermann C., Dagenais A., Berthiaume Y., Cardinaud B. et al., 2007/06. American journal of physiology. Lung cellular and molecular physiology, 292 (6) pp. L1422-31. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1CED7A946695]
 
Pneumonie à Pasteurella multocida compliquée de choc septique chez un patient non immunodéprimé [Pneumonia with septicemia caused by Pasteurella multocida in an immunocompetent patient]
Pukenyte E., Nguyen S., Le Berre R., Faure K., Viget N., Melliez H., Mira J.P., Guery B., Yazdanpanah Y., 2007/06. Medecine et maladies infectieuses, 37 (6) pp. 354-356. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AEAEE0BB6F49]
 
Targeting lung coagulation disorders in acute lung injury: easy as pie (PAI-1)?
Kipnis E., Guery B., 2007/05. Critical care medicine, 35 (5) pp. 1448-9; author reply 1449. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DAB6BD9F9627]
 
Inhaled nitric oxide increases endothelial permeability in Pseudomonas aeruginosa pneumonia.
Ader F., Le Berre R., Lancel S., Faure K., Viget N.B., Nowak E., Nevière R., Guery B.P., 2007/03. Intensive care medicine, 33 (3) pp. 503-510. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BF33532DE41D]
2006
 
Analysis of costs attributable to an outbreak of severe acute respiratory syndrome at a French hospital.
Yazdanpanah Y., Daval A., Alfandari S., Lenne X., Lavoine D., Verin I., Georges H., Leroy O., Senneville E., Guery B. et al., 2006/11. Infection control and hospital epidemiology, 27 (11) pp. 1282-1285. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_66FCD90BD79D]
 
Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector.
Epaulard O., Toussaint B., Quenee L., Derouazi M., Bosco N., Villiers C., Le Berre R., Guery B., Filopon D., Crombez L. et al., 2006/11. Molecular therapy, 14 (5) pp. 656-661. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4072164F6485]
 
Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia.
Robriquet L., Guery B., Fourrier F., 2006/09. Critical care medicine, 34 (9) pp. 2510; author reply 2510-1. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_19C9C7AE8921]
 
Quorum sensing: une nouvelle cible thérapeutique pour Pseudomonas aeruginosa [Quorum sensing: a new clinical target for Pseudomonas aeruginosa?]
Le Berre R., Faure K., Nguyen S., Pierre M., Ader F., Guery B., 2006/07. Medecine et maladies infectieuses, 36 (7) pp. 349-357. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EE0269ACE2BF]
 
Aspergillose pulmonaire aiguë invasive et pathologies pulmonaires chroniques [Acute invasive pulmonary aspergillosis in chronic lung disease - a review]
Ader F., Nseir S., Guery B., Tillie-Leblond I., 2006/06. Revue des maladies respiratoires, 23 (3 Suppl) pp. 6S11-6S20. Peer-reviewed.
[Pmid][serval:BIB_6CEE97B5091F]
 
Predictors of extubation failure in patients with chronic obstructive pulmonary disease.
Robriquet L., Georges H., Leroy O., Devos P., D'escrivan T., Guery B., 2006/06. Journal of critical care, 21 (2) pp. 185-190. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_18875EF8EEEA]
 
Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa.
Filopon D., Mérieau A., Bernot G., Comet J.P., Leberre R., Guery B., Polack B., Guespin-Michel J., 2006/05/30. BMC bioinformatics, 7 p. 272. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_95E9649ED696]
 
Effect of different stabilized preparations of peracetic acid on biofilm.
Loukili N.H., Granbastien B., Faure K., Guery B., Beaucaire G., 2006/05. The Journal of hospital infection, 63 (1) pp. 70-72. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3A4D46ADB435]
 
Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response.
Robriquet L., Collet F., Tournoys A., Prangère T., Nevière R., Fourrier F., Guery B.P., 2006/03/22. Respiratory research, 7 (1) p. 41. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_92FEAC3600A6]
 
Epidemiology and prognostic factors of critically ill patients treated with hemodiafiltration.
Soubrier S., Leroy O., Devos P., Nseir S., Georges H., d'Escrivan T., Guery B., 2006/03. Journal of critical care, 21 (1) pp. 66-72. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_91E9305ED972]
 
Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia.
Boussekey N., Leroy O., Alfandari S., Devos P., Georges H., Guery B., 2006/03. Intensive care medicine, 32 (3) pp. 469-472. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D6E8ECBD68E]
 
Prévention des infections liées aux cathéters veineux périphériques: Recommandations pour la pratique clinique. Service des recommandations professionnelles - Novembre 2005 [Prevention of peripheral venous catheter-related infections: Recommendations for clinical practice. Professional recommendations service: November 2005].
Boubon-Ribes AM, Chemorin C., Dellamonica P., Dupont H., Jacobs F., Marty N., Nitenberg G., Touratier S., Hajjar J., Verdeil X. et al., 2006/03. Medecine Therapeutique, 12 (3) pp. 218-222.
[serval:BIB_608DB7C7069E]
 
Pseudomonas aeruginosa et surfactant rôle de SP-A et SP-D [Pseudomonas aeruginosa and Surfactant-associated Proteins A and D]
Faure K., Leberre R., Guery B., 2006/02. Medecine et maladies infectieuses, 36 (2) pp. 63-71. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9FCF61491D5F]
 
Pseudomonas et bronches [Pseudomonas and the lung]
Groupe Entretiens du Club de Réfflexion sur l'Infection Respiratoire, Guery B., 2006/02. Revue de pneumologie clinique, 62 (1) pp. 7-11. Peer-reviewed.
[DOI][Pmid][serval:BIB_BAB48A1CD8C8]
 
Les antirétroviraux ont-ils une place dans le traitement du syndrome respiratoire aigu sévère? [Antiretroviral drugs in severe acute respiratory syndrome]
Yazdanpanah Y., Guéry B., 2006/01. Presse medicale, 35 (1 Pt 2) pp. 105-107. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FDB41EBAFF0F]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University